SA-01 | Is There a Need for a New Class of Pharmacotherapy for Treating ADHD?

19 May 2023 | 13:00 - 14:00 | Auditorium

001 | Unmet Treatment Needs in Adult ADHD and the Role of a New Class of Pharmacotherapy
Greg Mattingly, USA

SA-02 | Optimising treatment outcomes for adults with ADHD

20 May 2023 | 12:30 - 14:00 | Auditorium

Chair: Duncan Manders, UK

001 | Welcome! 
Duncan Manders, UK

002 | Evolution of amfetamines – history to current ADHD clinical practice
David Nutt, UK

003 | Individualising treatment for adults with ADHD – how can we achieve optimal outcomes? 
Kenny Handelman, Canada

004 | Utilising the range of treatments for ADHD in adults
Joe Johnson, UK

005 | Ask the Experts: Panel Forum - Optimising the treatment of ADHD in adults
All speakers +
Sara Binder, Canada
Jan Buitelaar, The Netherlands

006 | Closing comments
Duncan Manders, UK

LN-02 | Sleep disorder in ADHD children: Impact on Quality of Life for the child and family

19 May 2023 | 10:30 - 11:00 | Auditorium Lounge

Allan Hvolby, Denmark

LN-03 |Screening for adulthood ADHD and comorbidities using EarlyDetect

19 May 2023 | 12:30 - 13:00 | Auditorium Lounge

Pratap Chokka, Canada

LN-04 | Somatic Disorders and ADHD
 

20 May 2023 | 10:00 - 10:30 | Auditorium Lounge

James Kustow, UK

LN-05 | ADHD in women

20 May 2023 |12:00 - 12:30 | Auditorium Lounge

Lotta Borg Skoglund, Sweden